Mersana has announced positive results from preclinical studies for its second development candidate, XMT-1107. The studies showed that XMT-1107, a new analogue of fumagillin antiangiogenic conjugated FLEXIM (R) owned by Mersana showed a higher antitumor activity in xenograft tumor models in comparison with other antiangiogenic agents and extended exposure to the drug conjugate, supporting potential clinical utility of XMT-1107 as an anticancer agent.
"We are encouraged by the progress we are seeing today with XMT-1107, which addresses a new mechanism to inhibit proliferation of endothelial cells and has the potential to address a wide variety of angiogenic tumors, dijoJulie Olson, CEO of Mersana. "The first drugs in this class showed a promising activity in clinical practice but was interrupted due to the reversible neurological toxicity. The combination of our new" warhead "from fumagillin to FLEXIM using a specific link technology reduces exposure to the CNS in animal models for detection limits below. We hope moving XMT-1107 in clinical studies in early 2010. "
Mersana has announced positive results from preclinical studies for its second development candidate, XMT-1107. The studies showed that XMT-1107, a new analogue of fumagillin antiangiogenic conjugated FLEXIM (R) owned by Mersana showed a higher antitumor activity in xenograft tumor models in comparison with other antiangiogenic agents and extended exposure to the drug conjugate, supporting potential clinical utility of XMT-1107 as an anticancer agent.
"We are encouraged by the progress we are seeing today with XMT-1107, which addresses a new mechanism to inhibit proliferation of endothelial cells and has the potential to address a wide variety of angiogenic tumors, dijoJulie Olson, CEO of Mersana. "The first drugs in this class showed a promising activity in clinical practice but was interrupted due to the reversible neurological toxicity. The combination of our new" warhead "from fumagillin to FLEXIM using a specific link technology reduces exposure to the CNS in animal models for detection limits below. We hope moving XMT-1107 in clinical studies in early 2010. "
Deposits of gas condensate is formed at high pressures and high temperatures and therefore should be found at greater depths that the typical reservoirs of oil and gas. Many gas condensate reservoirs are found in the range of 3000 8000 psia and 200 400 ° F . These gas condensate deposits have a wide range of fluids in their composition.
Deposits of gas condensate is formed at high pressures and high temperatures and therefore should be found at greater depths that the typical reservoirs of oil and gas. Many gas condensate reservoirs are found in the range of 3000 8000 psia and 200 400 ° F . These gas condensate deposits have a wide range of fluids in their composition.
After two years of cramming and failing to repeat, an Argentine research team led by Dr. Gustavo Bianchi achieved for the first time polyacrylamides, a type of complex organic molecules key to clean up hazardous industrial liquid discharges heavily questioned, such as mining, paper manufacturing, the petroleum, gas, and the textile industry.
All of the above import large quantities of these polymers and pay between 3,000 and 8,000 dollars per tonne. Not only to clean water, but also because some use polyacrylamides in their processes to separate the useful from the useless.
After two years of cramming and failing to repeat, an Argentine research team led by Dr. Gustavo Bianchi achieved for the first time polyacrylamides, a type of complex organic molecules key to clean up hazardous industrial liquid discharges heavily questioned, such as mining, paper manufacturing, the petroleum, gas, and the textile industry.
All of the above import large quantities of these polymers and pay between 3,000 and 8,000 dollars per tonne. Not only to clean water, but also because some use polyacrylamides in their processes to separate the useful from the useless.